2.13
Diabetes Tipo I II: Fisiopatologia
O diabetes mellitus tipo 1 surge de uma destruição imunizada das células β pancreáticas, resultando em uma deficiência absoluta de insulina. Esse proc…
No diabetes tipo 1, fatores genéticos e ambientais contribuem para uma resposta autoimune, na qual o sistema imunológico ataca as células beta produtoras de insulina no pâncreas.
Essas células beta residem em aglomerados chamados ilhéus de Langerhans e são responsáveis pela produção de insulina, um hormônio que permite que a glicose entre nas células para energia ou armazenamento.
À medida que o processo autoimune se desenrola, as células T helper 1 são ativadas e liberam citocinas inflamatórias, como interferon-gama ou IFN-γ, e fator de necrose tumoral-alfa ou TNF-α.
O IFN-γ, em particular, ativa os macrófagos e fortalece a apresentação do antígeno. Esses sinais permitem que as células T citotóxicas ataquem e destruam as células beta, levando à insulite, marcada por inflamação e danos nas células beta nos ilhéus de Langerhans.
Com o tempo, a inflamação contínua destrói progressivamente as células beta, reduzindo drasticamente ou eliminando completamente a produção de insulina.
Sem insulina suficiente, a glicose não consegue entrar nas células do corpo e começa a se acumular na corrente sanguínea.
Esse acúmulo de açúcar no sangue leva a uma condição conhecida como hiperglicemia.
View the full transcript and gain access to JoVE Core videos
Q1: What role do the islets of Langerhans play in type 1 diabetes?
The islets of Langerhans are clusters of cells in the pancreas containing beta cells that produce insulin. In type 1 diabetes, these islets become inflamed through an autoimmune process called insulitis, where immune cells attack and destroy the insulin-producing beta cells, progressively reducing insulin production.
Q2: How do T helper 1 cells contribute to beta cell destruction in type 1 diabetes?
T helper 1 cells become activated against beta cell antigens and release pro-inflammatory cytokines, including interferon-gamma and tumor necrosis factor-alpha. These cytokines activate macrophages, enhance antigen presentation, and enable cytotoxic T cells to attack and destroy beta cells, perpetuating the autoimmune response.
Q3: What is the relationship between insulin deficiency and hyperglycemia in type 1 diabetes?
Insulin is required for glucose uptake into cells for energy or storage. Without sufficient insulin from destroyed beta cells, glucose cannot enter muscle and adipose tissue and accumulates in the bloodstream, causing hyperglycemia. This blood sugar buildup marks the clinical onset of type 1 diabetes.
Q4: How do genetic and environmental factors initiate the autoimmune response in type 1 diabetes?
Type 1 diabetes develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge. Genetic predisposition, including susceptibility alleles within HLA loci, influences autoimmune likelihood, while environmental triggers such as viral infections may precipitate or accelerate beta cell injury.
Q5: What is insulitis and how does it damage pancreatic beta cells?
Insulitis is an inflammatory infiltration of the islets of Langerhans characterized by T cells, macrophages, and other immune effectors. Chronic exposure to cytotoxic mediators from these immune cells leads to apoptosis and progressive depletion of beta cell mass, eventually eliminating insulin production capacity.
Q6: How does interferon-gamma amplify the immune attack on beta cells?
Interferon-gamma, released by activated T helper 1 cells, plays a central role in amplifying the immune response by promoting macrophage activation and enhancing antigen presentation. These enhanced signals allow cytotoxic T cells to more effectively recognize and attack beta cells, intensifying the autoimmune destruction.
Q7: What distinguishes type 1 diabetes from other forms of diabetes mellitus?
Type 1 diabetes results from immune-mediated destruction of pancreatic beta cells, causing absolute insulin deficiency. This contrasts with other diabetes types where insulin production may be preserved but ineffective. Understanding type 1 diabetes pathophysiology helps explain its acute onset and distinct clinical presentation compared to other forms.